SFE Investment Counsel - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 132 filers reported holding ANTARES PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
SFE Investment Counsel ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$180,000
+14.6%
44,0000.0%0.05%
+15.0%
Q4 2021$157,000
-1.9%
44,0000.0%0.04%
-11.1%
Q3 2021$160,000
-23.4%
44,000
-8.3%
0.04%
-21.1%
Q2 2021$209,000
-12.2%
48,000
-17.2%
0.06%
-17.4%
Q1 2021$238,000
-0.4%
58,000
-3.3%
0.07%
-9.2%
Q4 2020$239,000
+47.5%
60,0000.0%0.08%
+16.9%
Q3 2020$162,000
-1.8%
60,0000.0%0.06%
-11.0%
Q2 2020$165,000
+16.2%
60,0000.0%0.07%
-6.4%
Q1 2020$142,000
-49.6%
60,0000.0%0.08%
-32.2%
Q4 2019$282,000
+40.3%
60,0000.0%0.12%
+35.3%
Q3 2019$201,000
+2.0%
60,0000.0%0.08%
+1.2%
Q2 2019$197,000
+8.2%
60,0000.0%0.08%
+2.4%
Q1 2019$182,000
+11.7%
60,0000.0%0.08%
-1.2%
Q4 2018$163,000
-19.3%
60,0000.0%0.08%
+6.4%
Q3 2018$202,000
+30.3%
60,0000.0%0.08%
+21.9%
Q2 2018$155,000
+17.4%
60,0000.0%0.06%
-5.9%
Q1 2018$132,000
+10.9%
60,0000.0%0.07%
+41.7%
Q4 2017$119,000
-38.7%
60,0000.0%0.05%
-41.5%
Q3 2017$194,000
+0.5%
60,0000.0%0.08%
+5.1%
Q2 2017$193,000
+13.5%
60,0000.0%0.08%
+25.8%
Q1 2017$170,000
+38.2%
60,0000.0%0.06%
+31.9%
Q4 2016$123,000
+95.2%
60,0000.0%0.05%
+56.7%
Q3 2016$63,0000.0%60,0000.0%0.03%
+3.4%
Q2 2016$63,000
+21.2%
60,0000.0%0.03%
+20.8%
Q1 2016$52,000
-28.8%
60,0000.0%0.02%
-31.4%
Q4 2015$73,000
-28.4%
60,0000.0%0.04%
-28.6%
Q3 2015$102,000
-18.4%
60,0000.0%0.05%
-3.9%
Q2 2015$125,000
+83.8%
60,000
+140.0%
0.05%
+82.1%
Q1 2015$68,000
+6.2%
25,0000.0%0.03%
+7.7%
Q4 2014$64,000
+39.1%
25,0000.0%0.03%
+30.0%
Q3 2014$46,000
-31.3%
25,0000.0%0.02%
-25.9%
Q2 2014$67,000
-23.0%
25,0000.0%0.03%
-28.9%
Q1 2014$87,000
-22.3%
25,0000.0%0.04%
-22.4%
Q4 2013$112,000
+10.9%
25,0000.0%0.05%0.0%
Q3 2013$101,000
-19.2%
25,000
-16.7%
0.05%
-24.6%
Q2 2013$125,00030,0000.06%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders